Company News in the Life Science Industry

»

Reset 

Mérieux Equity Partners Announced That Benoit Chastaing Has Joined the Firm as Senior Partner

LYON, France, January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

AMSTERDAM, Jan. 17, 2019 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Azurion... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019

Scientists Develop Self-Dissolvable Antibacterial Bandages

MOSCOW, January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019

Asceneuron Appoints Peter Van Vlasselaer as Chairman

LAUSANNE, Switzerland and CAMBRIDGE, Ma., January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019

AstraZeneca and Mspharma Jordan Are Topping the List of the Best Places to Work in Jordan for 2018

AMMAN, Jordan, January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019

Cancer Immunotherapy Market to Gain US$124.88 Billion by 2024, Says TMR

ALBANY, New York, January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  Transparency Market Research

Elsevier's Reaxys PhD Prize 2019 for Students in the Chemical Sciences is Now Live

LONDON, January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  Elsevier Inc. | ELSEVIER INC. | Elsevier Inc., SciTech Connect

Cellular Biomedicine Group's AlloJoin® Therapy for Knee Osteoarthritis (KOA) Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials

SHANGHAI and NEW YORK, Jan. 17, 2019 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that its off-the-shelf... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  Cellular Biomedicine Group, Inc

Apollo Medical Holdings Announces The Appointment Of Linda Marsh And John Chiang To Its Board Of Directors

ALHAMBRA, Calif. and GLENDALE, Calif., Jan. 17, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, today announced the appointment of Linda Marsh and John Chiang to its Board of Directors.

... Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019

BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

FRANKLIN LAKES, N.J., Jan. 17, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported preliminary financial results for the first fiscal quarter ended December 31, 2018. Subject to the completion of its financial closing... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  Becton, Dickinson and Company (BD)

CBD And Advanced Wellness Company, RESET Bioscience, Debuts New Product With Highest Level Of Purity And Bioavailability

LOS ANGELES, Jan. 17, 2019 /PRNewswire/ -- RESET Bioscience (http://www.resetbioscience.com), a... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019

New Technology Helps Nephrologists Better Manage Patients with Chronic Kidney Disease

DENVER, Jan. 17, 2019 /PRNewswire/ -- DaVita Physician Solutions, a wholly owned subsidiary of DaVita... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  DaVita Inc.

Spineway: 2018 revenue of €6.5M

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Spineway

Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

SAN DIEGO, Jan. 16, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 1,612,903 shares of its common stock at a price to the public of $62.00 per share. The aggregate gross proceeds from this offering are expected to... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  Mirati Therapeutics, Inc.

AstraZeneca Lebanon Recognized as the Best Place To Work in Lebanon for 2018

BEIRUT, January 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2019

Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Gastric Cancer

SUZHOU, China, Jan. 16, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, announced today that the first patient has been dosed in a phase III clinical trial (ORIENT-16) that... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019
Related companies:  Innovent Biologics Co., Ltd.

Cardio Fitness DNA Testing Company Rightangled Joins the ABHI Innovation Hub at Dell Medical School in Austin

LONDON, Jan. 16, 2019 /PRNewswire/ -- Rightangled, a London based genetic testing company that was seed funded in 2017 by NHS England,... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019

Pharmaceutical and Life Sciences Real World Evidence: Market Landscape and Competitive Insights, 2018-2030

NEW YORK, Jan. 16, 2019 /PRNewswire/ -- The process of developing new and disruptive medical products involves heavy investments, both in terms of time and cost. Estimates suggest that each prescription drug requires an average of about 10 years and over USD 2.5 billion in workingcapital before... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019

Drug Adherence Enhancement Market: Devices and Applications, 2018-2030

NEW YORK, Jan. 16, 2019 /PRNewswire/ -- Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to be associated with negative health outcomes, inflated medical expenses, loss in productivity and, in certain cases, proves fatal as well. It has... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019

Global Biochips Industry

NEW YORK, Jan. 16, 2019 /PRNewswire/ -- This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others.

Read the full report: Read more ››

By: PR Newswire Association LLC. - 17 Jan 2019
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies